WEBINAR

Statistical challenges in Immuno-oncology trials: how to think outside the box and increase efficiency

WED, MAR 29, 2023 · 9:00 AM PDT · 12:00 PM EDT

Join Toby Batten, Statistics Manager at Veramed and our special guest co-host, Carlo Lanza (MD PhD), who brings 20+ years of Oncology experience with top 10 Pharma, as they discuss the evolution, challenges and road ahead of Clinical Oncology – focusing on Phase I, II and III specifically.

Carlo and Toby will share how to think outside the box from a clinical and statistical point of view, address common pitfalls, improve study design, and more.

Our special guest, Carlo Lanza, brings over 20 years of industry experience as a Clinical Lead in the field of Oncology and Hematology phase 1 to 4, working for companies such as Novartis, Astrazeneca, and Pfizer and supporting also smaller biotechs through early phase clinical studies.

Register to improve your analysis, efficiency and discover a new way of thinking in a fast changing world of clinical Oncology.

Register today.

 AGENDA

  • Immuno-oncology: What’s new and how does it change our interpretation of dose-toxicity data?
  • Designing early phase oncology studies: thinking outside the box
  • Considerations when selecting the recommended phase II dose and assessing early efficacy data
  • Looking to the future: Planning beyond early phase
  • Q&A session and attendee discussion

You can register for an earlier version of this webinar (11am BST) for our European audience here.

WEBINAR

Statistical challenges in Immuno-oncology trials: how to think outside the box and increase efficiency

WED, MAR 29, 2023 · 9:00 AM PDT · 12:00 PM EDT

Join Toby Batten, Statistics Manager at Veramed and our special guest co-host, Carlo Lanza (MD PhD), who brings 20+ years of Oncology experience with top 10 Pharma, as they discuss the evolution, challenges and road ahead of Clinical Oncology – focusing on Phase I, II and III specifically.

Carlo and Toby will share how to think outside the box from a clinical and statistical point of view, address common pitfalls, improve study design, and more.

Our special guest, Carlo Lanza, brings over 20 years of industry experience as a Clinical Lead in the field of Oncology and Hematology phase 1 to 4, working for companies such as Novartis, Astrazeneca, and Pfizer and supporting also smaller biotechs through early phase clinical studies.

Register to improve your analysis, efficiency and discover a new way of thinking in a fast changing world of clinical Oncology.

Register today.

 AGENDA

  • Immuno-oncology: What’s new and how does it change our interpretation of dose-toxicity data?
  • Designing early phase oncology studies: thinking outside the box
  • Considerations when selecting the recommended phase II dose and assessing early efficacy data
  • Looking to the future: Planning beyond early phase
  • Q&A session and attendee discussion

You can register for an earlier version of this webinar (11am BST) for our European audience here.

AGENDA

  • Immuno-oncology: What’s new and how does it change our interpretation of dose-toxicity data?
  • Designing early phase oncology studies: thinking outside the box
  • Considerations when selecting the recommended phase II dose and assessing early efficacy data
  • Looking to the future: Planning beyond early phase
  • Q&A session and attendee discussion

You can register for an earlier version of this webinar (11am BST) for our European audience here.

The presenters

Carlo Lanza

MD, PhD
Carlo Lanza, an MD who brings over 20 years of industry experience as a Clinical Lead in the field of Oncology and Hematology phase 1 to 4, working for companies such as Novartis, Astrazeneca, and Pfizer and supporting also smaller biotechs through early phase clinical studies.

Toby Batten

Statistics Manager, Veramed

Toby is a highly experienced Statistician with over 11 years of industry experience. He brings a diverse range of expertise and knowledge to the team, having worked across a vast array of therapeutic areas. As a natural leader and mentor to more junior Statisticians and Programmers at Veramed, Toby has developed extensive training and coaching material to help boost Veramed’s internal development. He is an excellent communicator and team player who leads client projects/portfolios effectively and collaborates closely with clients to help build trusted working relationships.

Meet Veramed

Veramed is a pioneering CRO redefining intelligent healthcare decision-making through end-to-end biometrics. We bring together people, innovation, and technology together with world-class governance to accelerate evidence generation and advance patient health. With skilled statisticians and programmers uniquely matched and scaled to client needs, we produce exceptional deliverables swiftly using a blend of skill, rigorous governance, and automation to optimize the speed and success of clinical research from design to submission and beyond.